Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

GWAS for discovery and replication of genetic loci associated with sudden cardiac arrest in patients with coronary artery disease.

Aouizerat BE, Vittinghoff E, Musone SL, Pawlikowska L, Kwok PY, Olgin JE, Tseng ZH.

BMC Cardiovasc Disord. 2011 Jun 10;11:29. doi: 10.1186/1471-2261-11-29.

2.

Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease.

Tseng ZH, Vittinghoff E, Musone SL, Lin F, Whiteman D, Pawlikowska L, Kwok PY, Olgin JE, Aouizerat BE.

Heart Rhythm. 2009 Dec;6(12):1745-50. doi: 10.1016/j.hrthm.2009.08.031. Epub 2009 Aug 28.

3.

Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease.

Refaat MM, Aouizerat BE, Pullinger CR, Malloy M, Kane J, Tseng ZH.

Heart Rhythm. 2014 Apr;11(4):646-52. doi: 10.1016/j.hrthm.2014.01.015. Epub 2014 Jan 17.

4.

Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest.

Arking DE, Reinier K, Post W, Jui J, Hilton G, O'Connor A, Prineas RJ, Boerwinkle E, Psaty BM, Tomaselli GF, Rea T, Sotoodehnia N, Siscovick DS, Burke GL, Marban E, Spooner PM, Chakravarti A, Chugh SS.

PLoS One. 2010 Mar 25;5(3):e9879. doi: 10.1371/journal.pone.0009879.

5.

Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study.

Aarnoudse AJ, Newton-Cheh C, de Bakker PI, Straus SM, Kors JA, Hofman A, Uitterlinden AG, Witteman JC, Stricker BH.

Circulation. 2007 Jul 3;116(1):10-6. Epub 2007 Jun 18.

6.

Genetic variation in angiotensin-converting enzyme-related pathways associated with sudden cardiac arrest risk.

Sotoodehnia N, Li G, Johnson CO, Lemaitre RN, Rice KM, Rea TD, Siscovick DS.

Heart Rhythm. 2009 Sep;6(9):1306-14. doi: 10.1016/j.hrthm.2009.06.013. Epub 2009 Jun 9.

7.

Novel loci associated with increased risk of sudden cardiac death in the context of coronary artery disease.

Huertas-Vazquez A, Nelson CP, Guo X, Reinier K, Uy-Evanado A, Teodorescu C, Ayala J, Jerger K, Chugh H; WTCCC+, Braund PS, Deloukas P, Hall AS, Balmforth AJ, Jones M, Taylor KD, Pulit SL, Newton-Cheh C, Gunson K, Jui J, Rotter JI, Albert CM, Samani NJ, Chugh SS.

PLoS One. 2013 Apr 4;8(4):e59905. doi: 10.1371/journal.pone.0059905. Print 2013.

8.

Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics Study.

Wauters E, Carruthers KF, Buysschaert I, Dunbar DR, Peuteman G, Belmans A, Budaj A, Van de Werf F, Lambrechts D, Fox KA.

Eur Heart J. 2013 Apr;34(13):993-1001. doi: 10.1093/eurheartj/ehs389. Epub 2012 Nov 15.

PMID:
23161703
9.

Genome-wide association study of coronary artery disease in the Japanese.

Takeuchi F, Yokota M, Yamamoto K, Nakashima E, Katsuya T, Asano H, Isono M, Nabika T, Sugiyama T, Fujioka A, Awata N, Ohnaka K, Nakatochi M, Kitajima H, Rakugi H, Nakamura J, Ohkubo T, Imai Y, Shimamoto K, Yamori Y, Yamaguchi S, Kobayashi S, Takayanagi R, Ogihara T, Kato N.

Eur J Hum Genet. 2012 Mar;20(3):333-40. doi: 10.1038/ejhg.2011.184. Epub 2011 Oct 5.

10.

Predicting sudden cardiac death using common genetic risk variants for coronary artery disease.

Hernesniemi JA, Lyytikäinen LP, Oksala N, Seppälä I, Kleber ME, Mononen N, März W, Mikkelsson J, Pessi T, Louhelainen AM, Martiskainen M, Nikus K, Klopp N, Waldenberger M, Illig T, Kähönen M, Laaksonen R, Karhunen PJ, Lehtimäki T.

Eur Heart J. 2015 Jul 7;36(26):1669-75. doi: 10.1093/eurheartj/ehv106. Epub 2015 Apr 23.

PMID:
25908775
11.

Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease.

Tseng ZH, Aouizerat BE, Pawlikowska L, Vittinghoff E, Lin F, Whiteman D, Poon A, Herrington D, Howard TD, Varosy PD, Hulley SB, Malloy M, Kane J, Kwok PY, Olgin JE.

Heart Rhythm. 2008 Jun;5(6):814-21. doi: 10.1016/j.hrthm.2008.03.016. Epub 2008 Mar 14.

12.

The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk.

Tragante V, Doevendans PA, Nathoe HM, van der Graaf Y, Spiering W, Algra A, de Borst GJ, de Bakker PI, Asselbergs FW; SMART study group.

Eur Heart J. 2013 Oct;34(37):2896-904. doi: 10.1093/eurheartj/eht222. Epub 2013 Jul 4.

PMID:
23828831
13.

A genome-wide association study of a coronary artery disease risk variant.

Lee JY, Lee BS, Shin DJ, Woo Park K, Shin YA, Joong Kim K, Heo L, Young Lee J, Kyoung Kim Y, Jin Kim Y, Bum Hong C, Lee SH, Yoon D, Jung Ku H, Oh IY, Kim BJ, Lee J, Park SJ, Kim J, Kawk HK, Lee JE, Park HK, Lee JE, Nam HY, Park HY, Shin C, Yokota M, Asano H, Nakatochi M, Matsubara T, Kitajima H, Yamamoto K, Kim HL, Han BG, Cho MC, Jang Y, Kim HS, Euy Park J, Lee JY.

J Hum Genet. 2013 Mar;58(3):120-6. doi: 10.1038/jhg.2012.124. Epub 2013 Jan 31.

PMID:
23364394
14.

[Genetic factors in myocardial infarction--Results from a candidate gene and a genome-wide approach between beta blockers].

Hengstenberg C, Bröckel U, Holmer S, Mayer B, Fischer M, Baessler A, Erdmann J, Lieb W, Löwel H, Riegger G, Schunkert H.

Herz. 2002 Nov;27(7):649-61. German. Erratum in: Herz. 2003 May;28(3):266.

PMID:
12439636
15.

A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese population.

Yamazaki K, Umeno J, Takahashi A, Hirano A, Johnson TA, Kumasaka N, Morizono T, Hosono N, Kawaguchi T, Takazoe M, Yamada T, Suzuki Y, Tanaka H, Motoya S, Hosokawa M, Arimura Y, Shinomura Y, Matsui T, Matsumoto T, Iida M, Tsunoda T, Nakamura Y, Kamatani N, Kubo M.

Gastroenterology. 2013 Apr;144(4):781-8. doi: 10.1053/j.gastro.2012.12.021. Epub 2012 Dec 22.

PMID:
23266558
16.

Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease.

Chen X, Li S, Yang Y, Yang X, Liu Y, Liu Y, Hu W, Jin L, Wang X.

J Thromb Haemost. 2012 Aug;10(8):1508-14. doi: 10.1111/j.1538-7836.2012.04815.x.

17.
18.

Genomic risk variants at 1p13.3, 1q41, and 3q22.3 are associated with subsequent cardiovascular outcomes in healthy controls and in established coronary artery disease.

Ellis KL, Frampton CM, Pilbrow AP, Troughton RW, Doughty RN, Whalley GA, Ellis CJ, Skelton L, Thomson J, Yandle TG, Richards AM, Cameron VA.

Circ Cardiovasc Genet. 2011 Dec;4(6):636-46. doi: 10.1161/CIRCGENETICS.111.960336. Epub 2011 Oct 7.

19.

Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study.

Theodoraki EV, Nikopensius T, Suhorutsenko J, Peppes V, Fili P, Kolovou G, Papamikos V, Richter D, Zakopoulos N, Krjutskov K, Metspalu A, Dedoussis GV.

BMC Med Genet. 2010 Feb 18;11:28. doi: 10.1186/1471-2350-11-28.

20.

Genetic variants at newly identified lipid loci are associated with coronary heart disease in a Chinese Han population.

Zhou L, Ding H, Zhang X, He M, Huang S, Xu Y, Shi Y, Cui G, Cheng L, Wang QK, Hu FB, Wang D, Wu T.

PLoS One. 2011;6(11):e27481. doi: 10.1371/journal.pone.0027481. Epub 2011 Nov 14.

Supplemental Content

Support Center